Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

An analysis looking at the hand bones of australopithecines, apes and humans reveals that tool use likely evolved before the ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

FDA clearance of HG202 marks a significant milestone for CRISPR/Cas13 RNA-editing in clinical applications ... The strong ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use ... The strong preclinical data for HG202, combined with promising results from the first-in-human ‘SIGHT-I’ trial ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...

Why is human culture—the shared body of knowledge passed down across generations—so much more powerful than animal cultures?

Feng Zhang, 2021 Richard Lounsbery Award recipient, will present the 2024 Lounsbery Lecture on "Exploration of Biological ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...